Monday, July 26, 2021

Pharma Reviews: Glenmark Life Sciences IPO opens Today; grey market premium at 20%, should you subscribe?

A subsidiary of Glenmark Pharmaceuticals, Glenmark Life Sciences is a ... “Indian API players could benefit as Chinese manufacturers battle strict ...
Read more: Glenmark Life Sciences IPO opens Today; grey market premium at 20%, should you subscribe?